Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BioBlock for COVID-19 Prevention
NCT05552950Phase 4Unknown
- Sponsor
- Chemi-Pharm
- Start
- May 2022
- Primary completion
- Jul 2023
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of covid-19 antibody nasal spray in coronavirus disease 2019 (COVID-19), sponsored by Chemi-Pharm. Status: unknown.
02
Drugs
covid-19 antibody nasal spray
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05552950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05552950.